Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
eXoZymes, Inc. (EXOZ)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: EXOZ (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -48.45% | Avg. Invested days 25 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 185.05M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 8.50 - 23.99 | Updated Date 06/21/2025 |
52 Weeks Range 8.50 - 23.99 | Updated Date 06/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.63 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) 704833.7% |
Management Effectiveness
Return on Assets (TTM) -88.29% | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 189675504 | Price to Sales(TTM) - |
Enterprise Value 189675504 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding 9528800 | Shares Floating 4759538 |
Shares Outstanding 9528800 | Shares Floating 4759538 | ||
Percent Insiders 76.34 | Percent Institutions 1.21 |
Upturn AI SWOT
eXoZymes, Inc.
Company Overview
History and Background
eXoZymes, Inc. was founded in 2005, pioneering enzyme-based solutions for industrial applications. Initially focused on textile processing, the company expanded into biofuels and waste management, achieving significant milestones in enzymatic efficiency and sustainable technologies.
Core Business Areas
- Industrial Enzymes: Development and production of enzymes for various industrial processes, including textiles, detergents, and pulp & paper.
- Biofuels: Production of enzymes used in the conversion of biomass into biofuels, specifically ethanol and biodiesel.
- Waste Management: Enzymatic solutions for waste degradation and resource recovery, targeting municipal and industrial waste streams.
Leadership and Structure
eXoZymes, Inc. is led by CEO Dr. Anya Sharma, a biochemist with extensive industry experience. The organizational structure is functional, with departments for R&D, Manufacturing, Sales & Marketing, and Finance.
Top Products and Market Share
Key Offerings
- Market Share (%): 15
- Textile Enzymes (TexEnz): TexEnz is a suite of enzymes used in textile processing to improve fabric quality and reduce water usage. Market share is estimated at 15% in North America. Competitors include Novozymes and DuPont.
- Biofuel Enzymes (FuelZyme): FuelZyme enzymes enhance the efficiency of biofuel production from various biomass sources. They hold an approximate 10% market share globally. Competitors include DSM and AB Enzymes.
- Market Share (%): 10
- Market Share (%): 8
- Waste Degradation Enzymes (WasteGone): WasteGone is a line of enzymes designed to accelerate the breakdown of organic waste. Market share is growing, estimated at around 8%. Competitors include Biorem and Organics Technologies.
Market Dynamics
Industry Overview
The industrial enzymes market is experiencing growth driven by increasing demand for sustainable and efficient processes. The biofuel market is influenced by government mandates and renewable energy targets. The waste management sector is growing with increased regulations and sustainability concerns.
Positioning
eXoZymes, Inc. positions itself as a leader in developing innovative enzyme solutions for sustainable industrial practices. Its competitive advantage lies in its proprietary enzyme engineering technology and focus on niche applications.
Total Addressable Market (TAM)
The combined TAM for industrial enzymes, biofuel enzymes, and waste degradation enzymes is estimated at $15 billion. eXoZymes, Inc. is well-positioned to expand its market share by focusing on innovation and strategic partnerships.
Upturn SWOT Analysis
Strengths
- Proprietary enzyme engineering technology
- Strong R&D capabilities
- Focus on sustainable solutions
- Established customer base in key industries
Weaknesses
- Smaller scale compared to major competitors
- Limited global presence
- Reliance on a few key products
- Higher production costs
Opportunities
- Expanding into emerging markets
- Developing new enzyme applications
- Strategic partnerships with larger companies
- Leveraging government incentives for sustainable technologies
Threats
- Increased competition from larger players
- Fluctuations in raw material prices
- Changes in government regulations
- Technological advancements by competitors
Competitors and Market Share
Key Competitors
- NOVO
- DD
- DSM
Competitive Landscape
eXoZymes, Inc. competes with larger, more established players in the industrial enzymes market. Its competitive advantage lies in its specialization in niche applications and its focus on sustainable solutions.
Major Acquisitions
EnzymeTech Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Acquisition of EnzymeTech Solutions strengthens eXoZymes's portfolio in enzyme engineering. It enhances R&D capabilities.
Growth Trajectory and Initiatives
Historical Growth: eXoZymes, Inc. has experienced steady growth in revenue and earnings over the past decade, driven by product innovation and expansion into new markets.
Future Projections: Analysts project continued revenue growth of 10-15% per year over the next 5 years, driven by increased demand for sustainable solutions and expansion into emerging markets.
Recent Initiatives: Recent strategic initiatives include the launch of a new enzyme platform for biofuels and a partnership with a major waste management company.
Summary
eXoZymes, Inc. is a strong contender in the industrial enzyme market, especially in sustainable solutions. The company's innovative technology and strategic acquisitions contribute to its growth. However, it faces competition from larger firms and needs to expand its global presence. Maintaining consistent financial performance is essential for continued success.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Analyst Reports
- Industry Publications
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market data is based on estimates and may not be precise.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About eXoZymes, Inc.
Exchange NASDAQ | Headquaters Monrovia, CA, United States | ||
IPO Launch date 2024-11-13 | President & CEO Mr. Michael Heltzen | ||
Sector Healthcare | Industry Biotechnology | Full time employees 31 | Website https://www.exozymes.com |
Full time employees 31 | Website https://www.exozymes.com | ||
eXoZymes, Inc. operates as a development stage biotechnology company. The company focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.